In Drug Price Debate, Pharma Turns Focus To Coverage, But Insurers Want Price Transparency
Executive Summary
At a conference on drug pricing, PhRMA CEO Castellani says the focus should be on making sure insurers are not discouraging use through high cost-sharing, while AHIP CEO Ignagni says the components of drug prices need to be transparent.